Serologic survey of the pandemic H1N1 2009 virus in Guangdong Province, China: A cross sectional study

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Zhang, Xin ^a   He, Jianfeng ^a   Li, Linghui ^a   Zhu, Xiaolan ^a   Ke, Changwen ^a   Ni, Hanzhong ^a   Hou, Nianmei ^a   Zhong, Haojie ^a   Wu, Jie ^a  

^a GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ADULT; AGE DISTRIBUTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CHINA; CITY; CONTROLLED STUDY; DISEASE SURVEILLANCE; EPIDEMIC; FEMALE; FEVER; FLU LIKE SYNDROME; GEOGRAPHY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFANT; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OCCUPATION; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; RURAL AREA; SCHOOL CHILD; SEROLOGY; SEX DIFFERENCE; SYMPTOMATOLOGY; ADOLESCENT; ANTIBODY PRODUCTION; BLOOD; CROSS-SECTIONAL STUDY; HEALTH CARE SURVEY; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; NEWBORN; PANDEMIC; STATISTICAL MODEL; STATISTICS;

ORTHOMYXOVIRIDAE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; GEOGRAPHY; HEALTH CARE SURVEYS; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; LOGISTIC MODELS; MALE; MIDDLE AGED; PANDEMICS; SEROLOGIC TESTS; YOUNG ADULT;

EID: 80051479523     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023034     Document Type: Article

References (27)

1. Neumann G, Noda T, Kawaoka Y, (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939.
2. Kilbourne ED, (2006) Influenza pandemics of the 20th century. Emerg Infect Dis 12: 9-14.
3. Chan M, (2009) World Health Organisation, World Now at Start of 2009 Influenza Pandemic (June 2009). Available:http://www.who.int/mediacenter/news/statements/2009/h1n1_pandemic_phase6_20090611/en/.
4. World Health Organisation, Pandemic A (H1N1) Update 59 (27 July 2009). Available:http://www.who.int/csr/disease/swineflu/updates/en/index.html.
5. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, et al. (2008) The global circulation of seasonal influenza A (H3N2) viruses. Science 320 (5874): 340-6.
6. Jianfeng H, Haojie Z, Zhengmin Z, Fen Y, Linghui L, et al. (2010) Characteristics of pandemic influenza A(H1N1) in Guangdong Province, 2009. South China J Prev Med 36 (1): 4-8.
7. Linghui L, Zhengmin Z, Jianfeng H, Haojie Z, Wenqing L, et al. (2010) Epidemiologic features of the severe and dead cases of influenza A (H1N1) in Guangdong Province. South China J Prev Med 36 (1): 17-20.
8. Collins SD, (1931) Age and sex incidence of influenza and pneumonia morbidity and mortality in the epidemic of 1928-29 with comparative data for the epidemic of 1918-19. Public Health Rep 33: 1909-37.
9. Chowell G, Bettencourt LM, Johnson N, Alonso WJ, Viboud C, (2008) The 1918-1919 influenza pandemic in England and Wales: spatial patterns in transmissibility and mortality impact. Proc Biol Sci 275: 501-9.
10. McSweeny K, Colman A, Fancourt N, Parnell M, Stantiall S, et al. (2007) Was rurality protective in the 1918 influenza pandemic in New Zealand? N Z Med J 120: U2579.
11. Cauchemez S, Donnelly CA, Reed C, Ghani AC, Fraser C, et al. (2009) Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 361: 2619-2627.
12. France AM, Jackson M, Schrag S, Lynch M, Zimmerman C, et al. (2010) Household transmission of 2009 influenza A (H1N1) virus after a school-based outbreak in New York City, April-May 2009. J Infect Dis 201: 984-992.
13. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, et al. (2009) Origins and evolutionary genomics of the 2009 swine origin H1N1 influenza A epidemic. Nature 459: 1122-5 DOI:10.1038/nature08182.
14. Hancock K, Veguilla V, Xiuhua L, Weimin Z, Butler EN, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-52 DOI:10.1056/NEJMoa0906453.
15. Danuta MS, Travis SH, Janet EM, Naveed ZJ, Suzana S, et al. (2011) Immuno- epidemiologic correlates of pandemic H1N1 surveillance observations: Higher antibody and lower cell-mediated immune responses with advanced age. JID 203: 158-167.
16. Chowell G, Bettencourt LM, Johnson N, Alonso WJ, Viboud C, (2008) The 1918-1919 influenza pandemic in England and Wales: spatial patterns in transmissibility and mortality impact. Proc Biol Sci 275: 501-9.
17. Jin HK, Ioanna S, Richard C, Joshy J, (2009) Origirinal Antigenic sin responses to influenza viruses. J Immunol 183: 3294-3301.
18. Shuang L, Hisanori D, Kavita BH, Min W, George H, (2009) Age-related alterations in innate immune receptor expression and ability of macrophages to respond to pathogen challenge in vitro. Mech ageing 130: 538-546.
19. Frasca D, Blomberg BB, (2009) Effects of aging on B cell function. Curr Opin Immunol 21: 425-30.
20. Phyllis JL, Kenneth D, (2004) Age-related changes in lymphocyte development and function. Nat Immunol 5: 133-9.
21. Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, Fonseca K, et al. (2009) Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 199 (2): 168-79.
22. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, et al. (2010) Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring - Summer 2009: four observational studies from Canada. PLoS Med 7 (4): e1000258.
23. Pebody R, Andrews N, Waight P, Malkani R, McCartney C, et al. (2011) No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England. Vaccine 29 (14): 2613-8.
24. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 325 (5937): 197-201.
25. World Health Organization WHO manual on animal influenza diagnosis and surveillance Geneva The Organization; 2002.
26. Committee for Proprietary Medicinal Products (1997) Note for guidance on harmonisation of requirements for influenza vaccines. London: European Agency for the Evaluation of Medicinal Products. CPMP/BWP/214/96 (circular no. 96-0666) pp. 1-22 Available:http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003945.pdf. Accessed 1 December 2010.
27. Potter CW, Oxford JS, (1979) Determinants of immunity to influenza infection in man. Br Med Bull 35 (1): 69-75.